03/12/2025
The International Day of Persons with Disabilities is a reminder that accessibility must be embedded into new medical developments. As the evidence base for psychedelic therapies continues to grow, it is very important that people with disabilities are not systematically excluded from clinical trials or overlooked in the development of future treatment guidelines.
As psychedelic interventions move closer to regulated clinical practice, considerations of equity become even more urgent. Disabled communities already face significant structural and financial barriers to care. Ensuring that emerging treatments are accessible, inclusive, and responsive to diverse needs is an essential step toward ethical and compassionate mental-health care.